Literature DB >> 20560148

Deletion of Ac-NMePhe(1) from [NMePhe(1) ]arodyn under acidic conditions, part 2: effects of substitutions on pharmacological activity.

Wei-Jie Fang1, Marco A Bennett, Thomas F Murray, Jane V Aldrich.   

Abstract

Arodyn (Ac[Phe¹,²,³,Arg⁴,D-Ala⁸]Dyn A(1-11)NH₂) is an acetylated dynorphin A (Dyn A) analog that is a potent and selective κ opioid receptor antagonist (Bennett et al., J Med Chem 2002, 45, 5617), and its analog [NMePhe¹]arodyn shows even higher affinity and selectivity for κ opioid receptors (Bennett et al., J Pept Res 2005, 65, 322). However, the latter compound is prone to deletion of the Ac-NMePhe moiety from the N-terminus of the peptide during acidic cleavage as described in the accompanying paper. Several stable analogs of [NMePhe¹]arodyn and [NMePhe¹,Trp³]arodyn where the acetyl group was substituted with a heteroatom-containing group were evaluated for their opioid receptor affinity, selectivity, and efficacy. Methoxycarbonyl derivatives exhibited the highest κ opioid receptor affinity among the analogs. Additional [CH₃OCO-NMePhe¹]arodyn analogs where position 3 was substituted with other aromatic or nonaromatic residues were also evaluated for κ receptor affinity, selectivity, and efficacy. [CH₃OCO-NMePhe¹]arodyn has similar κ opioid receptor affinity as [NMePhe¹]arodyn, retains high κ opioid receptor selectivity, and is a potent κ opioid receptor antagonist.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20560148      PMCID: PMC3411352          DOI: 10.1002/bip.21495

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  31 in total

1.  A novel N-terminal cyclic dynorphin A analogue cyclo(N,5)[Trp(3),Trp(4),Glu(5)] dynorphin A-(1-11)NH(2) that lacks the basic N-terminus.

Authors:  Balvinder S Vig; Thomas F Murray; Jane V Aldrich
Journal:  J Med Chem       Date:  2003-04-10       Impact factor: 7.446

2.  Bimorphinans as highly selective, potent kappa opioid receptor antagonists.

Authors:  A S Portoghese; A W Lipkowski; A E Takemori
Journal:  J Med Chem       Date:  1987-02       Impact factor: 7.446

3.  An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence.

Authors:  R B Rothman; D A Gorelick; S J Heishman; P R Eichmiller; B H Hill; J Norbeck; J G Liberto
Journal:  J Subst Abuse Treat       Date:  2000-04

4.  The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist.

Authors:  G H Rimoy; D M Wright; N K Bhaskar; P C Rubin
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

5.  Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.

Authors:  S Arttamangkul; J E Ishmael; T F Murray; D K Grandy; G E DeLander; B L Kieffer; J V Aldrich
Journal:  J Med Chem       Date:  1997-04-11       Impact factor: 7.446

6.  Effects of JDTic, a selective kappa-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model.

Authors:  F Ivy Carroll; Louis S Harris; Mario D Aceto
Journal:  Eur J Pharmacol       Date:  2005-10-19       Impact factor: 4.432

7.  The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide.

Authors:  A Agmo; C Belzung
Journal:  Neuropharmacology       Date:  1998       Impact factor: 5.250

8.  Structure-activity relationships of dynorphin a analogues modified in the address sequence.

Authors:  Georg Schlechtingen; Robert N DeHaven; Jeffrey D Daubert; Joel A Cassel; Nga N Chung; Peter W Schiller; Joseph P Taulane; Murray Goodman
Journal:  J Med Chem       Date:  2003-05-22       Impact factor: 7.446

9.  Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for human mu/kappa chimeras.

Authors:  J B Wang; P S Johnson; J M Wu; W F Wang; G R Uhl
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

10.  Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist.

Authors:  Ivy Carroll; James B Thomas; Linda A Dykstra; Arthur L Granger; Richard M Allen; James L Howard; Gerald T Pollard; Mario D Aceto; Louis S Harris
Journal:  Eur J Pharmacol       Date:  2004-10-06       Impact factor: 4.432

View more
  1 in total

1.  Alanine scan of the opioid peptide dynorphin B amide.

Authors:  Anand A Joshi; Thomas F Murray; Jane V Aldrich
Journal:  Biopolymers       Date:  2017-09       Impact factor: 2.505

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.